Awarded To:  Curtin University Perth
Dates:  2016-2019
Amount:  $15,000 (FAST portion)

 

FAST have joined forces with the Fragile X Association,  Prader Wili Association of Austrealia and the 15q Duplication Syndrome group to work with Professor Richard Norman from Curtin University who is arguably Australia's leading researcher and lecturer in health economics on a three year project to conduct a Health Economics Study. 

The rise in efficacy of testing for Angelman Syndrome means that newborn screening, with results being available in a short timeframe is possible for all four syndromes. A requirement for addition to the newborn screening program (NBS) is a Health Economics Study that will be submitted to State and Federal bodies.

With the increase in pace in Angelman Syndrome research and the real likelihood that for therapeutics will be available in the near future it is imperative that diagnosis be made as early as possible. We look forward to seeing the outcomes of this research and hope that it will result in earlier diagnosis and access to treatments.

 

 

 

Copyright © Foundation for Angelman Syndrome Therapeutics • Privacy Policy | Terms of Use
F.A.S.T. Australia • PO Box 248 • Salisbury • Queensland • 4107 • Phone 1300 078 108 • FAX 07 4032 5255